Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Pellkofer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2021
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA<sub>A</sub> receptor encephalitisSimone M Brändle, Manuela Cerina, Susanne Weber, et al.
Brain Pathology (Zurich, Switzerland)|February 19, 2017
Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelinationAlonso Barrantes-Freer, Aylin Sophie Engel, Odir Antonio Rodríguez-Villagra, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Neurology|January 27, 2022
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE<sup>NMO</sup> StudyMartin W Hümmert, Louisa M Schöppe, Judith Bellmann-Strobl, et al.
Neurology|December 5, 2019
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Neurology|September 29, 2020
Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.
Journal of Neuroinflammation|January 21, 2012
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsSven Jarius, Klemens Ruprecht, Brigitte Wildemann, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2021
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA<sub>A</sub> receptor encephalitisSimone M Brändle, Manuela Cerina, Susanne Weber, et al.
Brain Pathology (Zurich, Switzerland)|February 19, 2017
Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelinationAlonso Barrantes-Freer, Aylin Sophie Engel, Odir Antonio Rodríguez-Villagra, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Neurology|January 27, 2022
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE<sup>NMO</sup> StudyMartin W Hümmert, Louisa M Schöppe, Judith Bellmann-Strobl, et al.
Neurology|December 5, 2019
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Neurology|September 29, 2020
Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.
Journal of Neuroinflammation|January 21, 2012
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsSven Jarius, Klemens Ruprecht, Brigitte Wildemann, et al.
Pageof 2